Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07031037

Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders

This descriptive study aims primarily to characterize the sensory profile of patients with eating disorders (divided into three diagnostic groups: anorexia nervosa, boulimia nervosa and hyperphagia), controlling for possible autistic traits in this population.

The study involves measuring characteristics associated with eating disorders (diagnosis, BMI, anxiety), assessing the sensory profile (AASP), and coping strategies in patients with eating disorders who are hospitalised or followed up in consultation.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Eating Disorders Anorexia Nervosa Boulimia Nervosa Feeding and Eating Disorders Hyperphagia Mental Disorders Pathological Conditions, Signs and Symptoms Signs and Symptoms Signs and Symptoms, Digestive

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Esquirol Hospital Center

Limoges, New Aquitaine, 87025, France

Location contact

Alexandra Foucher, University degree

CONTACT

[email protected]

+33 5-55-43-11-00

Aude Paquet, PhD in Psychology

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Gender and Age: Male or female, aged 18 to 65
  • Confirmed diagnosis of anorexia nervosa (F50.01; F50.02), boulimia nervosa (F50.2), hyperphagic episodes (F50.8) or restriction or avoidance of food intake (F50.8) according to DSM-5 criteria
  • Hospitalization or consultation for Eating Disorder at Centre Hospitalier Esquirol
  • Consent: Free, informed, and written consent, signed by the participant and/or their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).

Exclusion criteria

  • Psychiatric comorbidity (non-tobacco addiction, characterized depressive episode, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders, neurodevelopmental disorder)
  • History of Eating Disorder other than current disorder
  • Proven sensory or neurological disability
  • Inability to understand questionnaires and information related to the study
  • Persons under psychiatric care in accordance with articles L. 3212-1 and L. 3213-1
  • Pregnant, nursing or parturient women
  • Adults subject to legal protection or unable to express their consent to express their consent
  • Persons not affiliated to a social security scheme or not benefiting from one social security scheme
  • Persons deprived of their liberty by judicial or administrative decision

Treatment and study plan

Scales

Other

Five questionnaires were administered at inclusion, socio-demographic and clinical data were collected during an interview (anxiety-depression, treatments).

The following questionnaires were used: The Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Eating Disorder Examination Self-Report Questionnaire (EDE-Q), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS), the Hospital anxiety and depression scale (HAD) and the Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2).

Primary outcomes

  1. Sensory profile from the Adolescent and Adult Sensory Profile (Brown and Dunn, 2002) according to each diagnostic group.

    Time frame: At enrollment

    Sensory profile scores will be obtained using the Adolescent and Adult Sensory Profile (AASP) scale during an individual interview after the participant has been included in the study. Subscores for sensory sensitivity, low registration, sensation seeking, and sensation avoidance will be collected. For each subscore, the minimum and maximum values range from 15 to 75. A high score indicates high sensory sensitivity.

  2. Scores for task coping drawn from the Coping Inventory for Stressful Situations (Endler & Parker, adapted by JP Rolland) according to each diagnostic group

    Time frame: at enrollment

    Coping scores will be obtained using the Coping Inventory for Stressful Situations (CISS) scale during an individual interview after the participant has been included in the study. The task-oriented coping subscore, emotion subscore, avoidance subscore, distraction subscore, and social diversion subscore will be collected. The minimum and maximum values range from 16 to 90. A high score indicates high oriented coping.

Secondary outcomes

  1. Description of the frequency of autistic traits for each diagnostic group

    Time frame: At enrollment

    The frequency of autistic traits will be obtained using the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr) during an individual interview after the participant has been included in the study. The minimum and maximum values range from 0 to 240. The generally accepted threshold for significant autistic traits is 70. A high score indicate high autistic traits.

  2. Description of the frequency of eating disorders for each diagnostic group.

    Time frame: At enrollment

    Eating disorders will be assessed using the Eating Disorder Examination Self-Report Questionnaire (EDE-Q) during an individual interview after the participant's inclusion. The EDE-Q, provide subscale scores reflecting the severity of aspects of the psychopathology of eating disorders. The subscales are Restraint, Eating Concern, Shape Concern and Weight Concern. For Restaint subscale minimum and maximum values range from 0 to 30. For Eating Concern subscale minimum and maximum values range from 0 to 30. For Shape Concern subscale minimum and maximum values range from 0 to 48. For Weight Concern subscale minimum and maximum values range from 0 to 30.

    The higher the score, the more severe the symptoms.

  3. Anxiety according to each diagnostic group.

    Time frame: At enrollment

    Anxiety and depression will be obtained using the Hospital Anxiety and Depression Scale (HAD) during an individual interview after the participant's inclusion. The anxiety subscore will be collected. Minimum and maximum values range from 0 to 21. The generally accepted threshold for significant anxiety is 11.

  4. Body awareness from the multidimensional assessment of interoceptive awareness for each diagnostic group.

    Time frame: At enrollment

    Body awareness will be obtained using the Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2) scale during an individual interview after the participant's inclusion. Minimum and maximum values range from 0 to 185. A high score indicates high interoceptive awareness.

Study contacts

Contact information is provided by the study sponsor or research team.

Aude Paquet, PhD in Psychology

CONTACT

[email protected]

+33 5-55-43-11-27

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Esquirol

Other

Registry information

Acronym: SensoryCop

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Jun 22, 2025
Registry last updated
Jun 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.